Domain > www.relmada.com

More information on this domain is in AlienVault OTX

Whois

Property	Value
Name	Relmada
Organization	Relmada
Email	st@relmada.com
Address	138 Canterbury Lane
Zip Code	19422
City	Blue Bell
State	PA
Country	US
Phone	917-405-1305
NameServer	NS11.HUMBLEMONKEY.COM
Created	2011-04-26 00:19:04
Changed	2015-04-26 00:30:30
Expires	2025-04-26 00:00:00
Registrar	NETWORK SOLUTIONS, L

DNS Resolutions

Date	IP Address
2020-02-06	34.225.120.54 (ClassC)
2020-07-16	54.227.147.28 (ClassC)
2022-01-21	3.225.74.242 (ClassC)
2023-06-04	54.204.13.102 (ClassC)
2023-09-27	54.145.232.231 (ClassC)
2023-12-22	54.225.202.48 (ClassC)
2024-07-18	44.209.57.54 (ClassC)
2024-10-22	184.73.186.24 (ClassC)
2025-05-25	184.169.227.74 (ClassC)
2025-06-09	52.9.46.151 (ClassC)
2025-07-13	13.56.34.134 (ClassC)
2025-07-27	54.183.51.106 (ClassC)
2025-08-14	35.171.156.239 (ClassC)
2025-08-30	54.177.186.41 (ClassC)
2025-09-08	13.57.115.221 (ClassC)
2025-10-21	13.52.39.81 (ClassC)
2026-01-26	52.9.155.122 (ClassC)

HTTP/1.1 200 OKDate: Sun, 25 May 2025 12:55:22 GMTServer: ApacheX-Frame-Options: SAMEORIGINStrict-Transport-Security: max-age31536000;X-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffFeatu

!DOCTYPE html>html langen>    head>        meta http-equivx-ua-compatible contentieedge>        meta charsetutf-8>                        link relalternate typeapplication/rss+xml titleRelmada Therapeutics, Inc. - Recent News hrefhttps://www.relmada.com/for-investors/news/rss />                        title>Relmada Therapeutics, Inc. (RLMD)/title>                link relcanonical hrefhttps://www.relmada.com>meta propertyog:url contenthttps://www.relmada.com>meta propertyog:site_name contentRelmada Therapeutics, Inc.>meta propertyog:title contentRelmada Therapeutics, Inc.>meta propertyog:type contentwebsite>meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_377254c0e2cc05f087f0c82760331809/relmada/db/322/2296/social_image_resized.jpg>meta nametwitter:card contentsummary_large_image>script typeapplication/ld+json>	{@context:http://schema.org,@type:Corporation,name:Relmada Therapeutics, Inc.,address:{@type:PostalAddress,streetAddress:880 Third Avenue 12th Floor,addressLocality:New york, NY,postalCode:10022,addressCountry:United States},legalName:Relmada Therapeutics, Inc.,description:Relmada (NASDAQ: RLMD) is a late-stage biotech company focused upon addressing diseases of the central nervous symptom (CNS) in an entirely new way. Our lead program, REL-1017, is a novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission and is in development for the adjunctive treatment of major depressive disorder. Data from the Phase 2 trial with REL-1017 suggest rapid and sustained antidepressant effects with statistically significant improvements as compared to placebo on all measured efficacy measures. The Phase 2 study data also suggest a favorable safety and tolerability profile of REL-1017 relative to placebo-treated patients on a background of anti-depressant therapy (ADT) The U.S. Food and Drug Administration has granted Fast Track designation for REL-1017 as an adjunctive treatment of MDD.,tickerSymbol:: RLMD,

Subdomains

Date	Domain	IP
ir.relmada.com	2024-06-28	13.56.154.239
www.relmada.com	2025-05-25	184.169.227.74

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > www.relmada.com

Is this malicious?

Whois

DNS Resolutions

Port 443

Subdomains